IH
Highly rated in
17
conditions
Highly rated in
17
conditions
Check Dr. Ikuo Hirano's experience treating your condition:
About Dr. Ikuo Hirano

Ikuo Hirano is a Gastroenterologist in Chicago, Illinois. Hirano has been practicing medicine for over 33 years and is highly rated in 17 conditions, according to our data. His top areas of expertise are Eosinophilic Esophagitis, Esophagitis, Swallowing Difficulty, Viral Gastroenteritis, and Endoscopy. He is licensed to treat patients in Illinois. Hirano is currently accepting new patients.

His clinical research consists of co-authoring 166 peer reviewed articles and participating in 14 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Ikuo Hirano it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Ikuo Hirano accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Cigna

Call to see if your plan is accepted.
Locations
259 E Erie St, Chicago, IL 60611
Background & Education
Graduate Institution
Perelman School Of Med At The University Of Pennsylvania, 1990
Specialties
Gastroenterology
Licenses
Internal Medicine in IL
Hospital Affiliations
Northwestern Medicine Lake Forest Hospital
Northwestern Medicine McHenry Hospital
Northwestern Medicine Central DuPage Hospital
Northwestern Memorial Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


14 Clinical Trials

A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
A Multi-center, Randomized, Double Blind, Parallel-arm, Placebo Controlled Trial of Mepolizumab for Treatment of Adults and Adolescents With Active Eosinophilic Esophagitis and Dysphagia-predominant Symptoms
Six Food vs One Food Eosinophilic Esophagitis Elimination Diet (SOFEED) Followed by Swallowed Glucocorticoid Trial
View 12 Less Clinical Trials -

185 Total Publications

Editorial: cooking up something new for diet therapy of eosinophilic oesophagitis.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors